Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 4Vitamin D Deficiency 3Prostatic Neoplasms 3Leukemia, Lymphocytic, Chronic, B-Cell 2Triple Negative Breast Neoplasms 1Subcutaneous panniculitis-like T-cell lymphoma 1Psoriasis 1Osteoporosis Secondary 1Osteoarthritis 1Obesity 1Neoplasms 1Lymphoma, T-Cell 1Lymphoma, Primary Cutaneous Anaplastic Large Cell 1Lymphoma, Non-Hodgkin 1Lymphoma, Large-Cell, Anaplastic 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Extranodal NK-T-Cell 1Immunoblastic Lymphadenopathy 1Fractures, Stress 1Enteropathy-Associated T-Cell Lymphoma 1Colorectal Adenocarcinoma 1Colonic Neoplasms 1Cardiovascular Diseases 1Carcinoma, Intraductal, Noninfiltrating 1Bone Metabolism Biomarkers 1Autoimmune Diseases 1Arthritis, Rheumatoid 1

Interventions

pembrolizumab 97Carboplatin 68Paclitaxel 57Cyclophosphamide 41Capecitabine 31Specimen Handling 28sacituzumab govitecan 26130-nm albumin-bound paclitaxel 25Gemcitabine 22olaparib 21Magnetic Resonance Spectroscopy 21Doxorubicin 21Taxes 20Albumin-Bound Paclitaxel 20Biopsy 19Drug Therapy 16Nivolumab 15atezolizumab 14toripalimab 12Radiotherapy 12Epirubicin 12durvalumab 11eribulin 10Docetaxel 10Cisplatin 10Bevacizumab 10fludarabine 8Standard of Care 7Radiation 7Injections 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Triple Negative Breast Neoplasms × Cholecalciferol × 1 year × Clear all
NCT04677816 2026-04-14

Impact of Vitamin D Supplementation on the Rate of Pathologic Complete Response in Vitamin D Deficient Patients

Wake Forest University Health Sciences

Phase 2 Recruiting
50 enrolled
Breast

Vitamin D Deficiency, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡